TY  - GEN
AU  - Pless,Miklos
AU  - Belhadj,Karim
AU  - Menssen,Hans D
AU  - Kern,Wolfgang
AU  - Coiffier,Bertrand
AU  - Wolf,Jürgen
AU  - Herrmann,Richard
AU  - Thiel,Eckhard
AU  - Bootle,Doug
AU  - Sklenar,Ivo
AU  - Müller,Christian
AU  - Choi,Les
AU  - Porter,Carl
AU  - Capdeville,Renaud
TI  - Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study
SN  - 1078-0432
PY  - 2004///1019
KW  - Adenosylmethionine Decarboxylase
KW  - antagonists & inhibitors
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Amidines
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Indans
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Polyamines
KW  - Prognosis
KW  - Recurrence
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.ccr-0977-03
ER  -